The present invention relates to the
medicine technical field and concretely indicates an application of alpha-hydroxy acid for preparing a cancerous tumour internal injection treatment
drug. The alpha-hydroxy acid of the present invention indicates hydroxyacetic acid or alpha-
hydracrylic acid. With the present invention, the hydroxyacetic acid
aqueous solution with different concentrations is prepared to be processed for
medicine efficacy tests such as a naked rat experiment, a rat experiment and a
cell test, which are compared with the
medicine efficacy of electropositive medicine
acetic acid used for
liver cancer internal injection which has the same concentration with the hydroxyacetic acid
aqueous solution. The naked rat experiment and a
rat liver damnification experiment show that under the same concentration, the hydroxyacetic acid has similar anti-liver-
cancer effect as and even better anti-liver-
cancer effect than the
acetic acid. The
cell test shows that the hydroxyacetic acid is applied to the tumour internal injection with great inhibiting effect towards
hepatic tumour, pulmonary tumour, oesophagus tumour, etc. The present invention also approves that the alpha-
hydracrylic acid (
lactic acid) has similar anticancer effect as the hydroxyacetic acid. The present invention provides the novel cancerous tumour internal injection treatment
drug which has strong inhibiting effect towards tumour cells, such as the
hepatic tumour, the pulmonary tumour, the oesophagus tumour, etc.